260 related articles for article (PubMed ID: 37246320)
21. Beneficial Effects of Walnuts on Cognition and Brain Health.
Chauhan A; Chauhan V
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32093220
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D, Cognition and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails.
Landel V; Annweiler C; Millet P; Morello M; Féron F
J Alzheimers Dis; 2016 May; 53(2):419-44. PubMed ID: 27176073
[TBL] [Abstract][Full Text] [Related]
23. VITAMIN D IN ALZHEIMER'S DISEASE - PROPHYLAXIS OR THERAPY?
Gruber-Bzura BM
Acta Pol Pharm; 2016 Nov; 73(6):1427-1431. PubMed ID: 29634094
[TBL] [Abstract][Full Text] [Related]
24. Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture: insights into Alzheimer's disease.
Butterfield DA; Koppal T; Subramaniam R; Yatin S
Rev Neurosci; 1999; 10(2):141-9. PubMed ID: 10658956
[TBL] [Abstract][Full Text] [Related]
25. Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform.
Kolaj I; Imindu Liyanage S; Weaver DF
Neurochem Int; 2018 Nov; 120():99-111. PubMed ID: 30098379
[TBL] [Abstract][Full Text] [Related]
26. Effects of vitamin D in an animal model of Alzheimer's disease: behavioral assessment with biochemical investigation of Hippocampus and serum.
Mehri N; Haddadi R; Ganji M; Shahidi S; Soleimani Asl S; Taheri Azandariani M; Ranjbar A
Metab Brain Dis; 2020 Feb; 35(2):263-274. PubMed ID: 31853828
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease.
Landel V; Millet P; Baranger K; Loriod B; Féron F
Mol Neurodegener; 2016 Mar; 11():22. PubMed ID: 26932723
[TBL] [Abstract][Full Text] [Related]
28. Metals, oxidative stress and neurodegenerative disorders.
Jomova K; Vondrakova D; Lawson M; Valko M
Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D basis of Alzheimer's disease: from genetics to biomarkers.
Dursun E; Gezen-Ak D
Hormones (Athens); 2019 Mar; 18(1):7-15. PubMed ID: 30484096
[TBL] [Abstract][Full Text] [Related]
30. Effects of vitamin D supplementation on cognitive function and blood Aβ-related biomarkers in older adults with Alzheimer's disease: a randomised, double-blind, placebo-controlled trial.
Jia J; Hu J; Huo X; Miao R; Zhang Y; Ma F
J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1347-1352. PubMed ID: 31296588
[TBL] [Abstract][Full Text] [Related]
31. Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model.
Lv J; Ma S; Zhang X; Zheng L; Ma Y; Zhao X; Lai W; Shen H; Wang Q; Ji J
J Proteomics; 2014 Oct; 110():45-58. PubMed ID: 25108202
[TBL] [Abstract][Full Text] [Related]
32. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.
Butterfield DA; Reed T; Newman SF; Sultana R
Free Radic Biol Med; 2007 Sep; 43(5):658-77. PubMed ID: 17664130
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective effects of vitamin D in an Alzheimer's disease rat model: Improvement of mitochondrial dysfunction via calcium/calmodulin-dependent protein kinase kinase 2 activation of Sirtuin1 phosphorylation.
Mohanad M; Mohamed SK; Aboulhoda BE; Ahmed MAE
Biofactors; 2024; 50(2):371-391. PubMed ID: 37801071
[TBL] [Abstract][Full Text] [Related]
34. Non-genomic rewiring of vitamin D receptor to p53 as a key to Alzheimer's disease.
Lai RH; Hsu YY; Shie FS; Huang CC; Chen MH; Juang JL
Aging Cell; 2021 Dec; 20(12):e13509. PubMed ID: 34725922
[TBL] [Abstract][Full Text] [Related]
35. Increased Electron Paramagnetic Resonance Signal Correlates with Mitochondrial Dysfunction and Oxidative Stress in an Alzheimer's disease Mouse Brain.
Fang D; Zhang Z; Li H; Yu Q; Douglas JT; Bratasz A; Kuppusamy P; Yan SS
J Alzheimers Dis; 2016; 51(2):571-80. PubMed ID: 26890765
[TBL] [Abstract][Full Text] [Related]
36. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
Behl T; Kaur I; Fratila O; Brata R; Bungau S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
[TBL] [Abstract][Full Text] [Related]
37. MGAT3 mRNA: a biomarker for prognosis and therapy of Alzheimer's disease by vitamin D and curcuminoids.
Fiala M; Mahanian M; Rosenthal M; Mizwicki MT; Tse E; Cho T; Sayre J; Weitzman R; Porter V
J Alzheimers Dis; 2011; 25(1):135-44. PubMed ID: 21368380
[TBL] [Abstract][Full Text] [Related]
38. Impact of Vitamin D on amyloid precursor protein processing and amyloid-β peptide degradation in Alzheimer's disease.
Grimm MO; Lehmann J; Mett J; Zimmer VC; Grösgen S; Stahlmann CP; Hundsdörfer B; Haupenthal VJ; Rothhaar TL; Herr C; Bals R; Grimm HS; Hartmann T
Neurodegener Dis; 2014; 13(2-3):75-81. PubMed ID: 24192346
[TBL] [Abstract][Full Text] [Related]
39. A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks.
Mecocci P; Boccardi V; Cecchetti R; Bastiani P; Scamosci M; Ruggiero C; Baroni M
J Alzheimers Dis; 2018; 62(3):1319-1335. PubMed ID: 29562533
[TBL] [Abstract][Full Text] [Related]
40. Role of Oxidative Stress and Metal Toxicity in the Progression of Alzheimer's Disease.
Birla H; Minocha T; Kumar G; Misra A; Singh SK
Curr Neuropharmacol; 2020; 18(7):552-562. PubMed ID: 31969104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
